RxDoctor Payments Data

James Blankenship, MD

Neurological Surgery · Fayetteville, ARNPI 1245202274

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $168,388 of the $217,385 with a category attached, or 77.5%. The Institute Of Musculoskeletal Science And Education accounts for 91.0% of it on its own, with 6 other manufacturers making up the rest. Among neurological surgery clinicians in AR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$217,385in general payments, 2019–2025

Across 78 payments — averaging $2786.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • The Institute Of Musculoskeletal Science And Education$198K
  • Camber Spine Technologies LLC$19K
  • Philadelphia Medical Management Company LLC$321
  • Shockwave Medical, Inc$80
  • Midsouth Orthopedics Inc.$54
  • Abbott$40
  • plus $11 from 1 others
$100,000in ownership & investment interests, 2019–2025

Across 6 payments — averaging $16,667 each. An ownership or investment interest held by the physician or an immediate family member.

  • Philadelphia Medical Management Company LLC$100K

What the payments were for

  • Royalty or licence$168,38877%
  • Consulting fees$39,78518%
  • Speaking & faculty fees$1,6001%
  • Travel & lodging$6,5453%
  • Food & beverage$7460%
  • Ownership interest$3210%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$217,385 in reported general payments places this provider in the 95th percentile of 64 neurological surgery providers in Arkansas.

See all neurological surgery providers in Arkansas

Medicare billing

Part B allowed, 2024
$161,825
Medicare patients
126
Services billed
779

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen92$978
Gabapentin101$970
Pregabalin41$780
Celecoxib24$398
Meloxicam149$340
Oxycodone Hcl35$251
Clindamycin Hcl42$178
Ondansetron OdtOndansetron24$144
Tramadol Hcl38$144
Baclofen23$119
Levofloxacin32$91

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Fayetteville

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →